Back to results
US 11,492,378 B2Granted
Antibacterial protein EFAL-2 having bacteriolytic ability with respect to Enterococcus faecium
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Myung Soo Kang, Soo Youn Jun, Jong Hyun Kim, Gi Mo Jung, Jee Soo Son, Hyoun Rok Paik, Sang Hyeon Kang
Life of this patent
Estimating the term…
Abstract
The present invention relates to an antibacterial protein EFAL-2 derived from bacteriophage Ent-FAP-4 (Accession number: KCTC 12854BP), which has the ability to kill Enterococcus faecium and an amino acid sequence represented by SEQ ID NO: 2, a pharmaceutical composition containing the same as an active ingredient, and a method for preventing or treating diseases caused by Enterococcus faecium using the pharmaceutical composition.
Claims1
A method for treating endocarditis caused by Enterococcus faecium, the method comprising:
- administering to a subject a composition comprising an antibacterial protein having bacteriolytic ability against Enterococcus faecium, and consisting of the amino acid sequence represented by SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.